ASX - By Stock
|
NOX |
Re:
Ann: Appendix 4D and Half Year 2024 Financial Report
|
|
cenny22
|
33 |
13K |
0 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
33
|
13K
|
0
|
|
ASX - By Stock
|
SDV |
Re:
Ann: March 2024 Quarterly Report / Appendix 4C
|
|
cenny22
|
18 |
5.6K |
2 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
18
|
5.6K
|
2
|
|
ASX - By Stock
|
SDV |
Re:
Ann: March 2024 Quarterly Report / Appendix 4C
|
|
cenny22
|
18 |
5.6K |
1 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
18
|
5.6K
|
1
|
|
ASX - By Stock
|
SDV |
Re:
Ann: SciDev Awarded New PFAS Contract in Victoria
|
|
cenny22
|
3 |
1.0K |
6 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
3
|
1.0K
|
6
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Noxopharm extends Hudson Institute strategic partnership
|
|
cenny22
|
3 |
1.7K |
1 |
15/02/24 |
15/02/24 |
ASX - By Stock
|
3
|
1.7K
|
1
|
|
ASX - By Stock
|
AVZ |
Re:
Ann: Manono Project Mineral Resource increases 47% to 842Mt
|
|
cenny22
|
305 |
150K |
3 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
305
|
150K
|
3
|
|
ASX - By Stock
|
NOX |
Re:
the next Disallowed
|
|
cenny22
|
11 |
6.7K |
1 |
06/01/24 |
06/01/24 |
ASX - By Stock
|
11
|
6.7K
|
1
|
|
ASX - By Stock
|
SDV |
Re:
Ann: September 2023 Quarterly Report
|
|
cenny22
|
11 |
4.0K |
0 |
26/10/23 |
26/10/23 |
ASX - By Stock
|
11
|
4.0K
|
0
|
|
ASX - By Stock
|
NOX |
Re:
Ann: mRNA Vaccine Enhancer Shows Inflammation Reduction
|
|
cenny22
|
45 |
18K |
1 |
18/10/23 |
18/10/23 |
ASX - By Stock
|
45
|
18K
|
1
|
|
ASX - By Stock
|
SDV |
Re:
Ann: Audited FY 2023 Financial Statements and App 4E
|
|
cenny22
|
14 |
4.9K |
4 |
30/08/23 |
30/08/23 |
ASX - By Stock
|
14
|
4.9K
|
4
|
|
ASX - By Stock
|
SDV |
Re:
Ann: June 2023 Quarterly Report
|
|
cenny22
|
11 |
5.4K |
2 |
05/08/23 |
05/08/23 |
ASX - By Stock
|
11
|
5.4K
|
2
|
|
ASX - By Stock
|
SDV |
Re:
News: SDV Scidev Says Qtrly Revenue Of A$21.1M Up 60% Versus Pcp
|
|
cenny22
|
4 |
1.9K |
1 |
19/04/23 |
19/04/23 |
ASX - By Stock
|
4
|
1.9K
|
1
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Noxopharm to Prioritise Cutting-Edge Chroma & Sofra Programs
|
|
cenny22
|
67 |
27K |
5 |
06/04/23 |
06/04/23 |
ASX - By Stock
|
67
|
27K
|
5
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Noxopharm to Prioritise Cutting-Edge Chroma & Sofra Programs
|
|
cenny22
|
67 |
27K |
3 |
06/04/23 |
06/04/23 |
ASX - By Stock
|
67
|
27K
|
3
|
|
ASX - By Stock
|
NOX |
Re:
IONIC may yet be a winner
|
|
cenny22
|
55 |
17K |
1 |
22/03/23 |
22/03/23 |
ASX - By Stock
|
55
|
17K
|
1
|
|
ASX - By Stock
|
AVZ |
Re:
Running discussion on SP
|
|
cenny22
|
81K |
48M |
7 |
15/12/22 |
15/12/22 |
ASX - By Stock
|
81K
|
48M
|
7
|
|
ASX - By Stock
|
SDV |
Re:
Ann: 2022 AGM Results
|
|
cenny22
|
3 |
1.9K |
1 |
16/11/22 |
16/11/22 |
ASX - By Stock
|
3
|
1.9K
|
1
|
|
ASX - By Stock
|
NOX |
Re:
AGM
|
|
cenny22
|
46 |
11K |
0 |
09/11/22 |
09/11/22 |
ASX - By Stock
|
46
|
11K
|
0
|
|
ASX - By Stock
|
SDV |
Re:
Ann: SciDev Ltd 2022 Annual Report
|
|
cenny22
|
2 |
1.7K |
3 |
22/10/22 |
22/10/22 |
ASX - By Stock
|
2
|
1.7K
|
3
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Noxopharm 2022 Annual Report
|
|
cenny22
|
38 |
12K |
1 |
08/10/22 |
08/10/22 |
ASX - By Stock
|
38
|
12K
|
1
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Noxopharm 2022 Annual Report
|
|
cenny22
|
38 |
12K |
1 |
07/10/22 |
07/10/22 |
ASX - By Stock
|
38
|
12K
|
1
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Noxopharm 2022 Annual Report
|
|
cenny22
|
38 |
12K |
8 |
07/10/22 |
07/10/22 |
ASX - By Stock
|
38
|
12K
|
8
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Noxopharm 2022 Annual Report
|
|
cenny22
|
38 |
12K |
0 |
07/10/22 |
07/10/22 |
ASX - By Stock
|
38
|
12K
|
0
|
|
ASX - By Stock
|
SDV |
Re:
Ann: Q4FY2022 Webinar Details
|
|
cenny22
|
13 |
7.4K |
1 |
10/08/22 |
10/08/22 |
ASX - By Stock
|
13
|
7.4K
|
1
|
|
ASX - By Stock
|
SDV |
Re:
Ann: Q4FY2022 Webinar Details
|
|
cenny22
|
13 |
7.4K |
2 |
28/07/22 |
28/07/22 |
ASX - By Stock
|
13
|
7.4K
|
2
|
|
ASX - By Stock
|
NOX |
Re:
Are we expecting any news from NOX in near future?
|
|
cenny22
|
72 |
23K |
0 |
28/07/22 |
28/07/22 |
ASX - By Stock
|
72
|
23K
|
0
|
|
ASX - By Stock
|
SDV |
Re:
Ann: Resignation of CEO
|
|
cenny22
|
38 |
26K |
2 |
30/04/22 |
30/04/22 |
ASX - By Stock
|
38
|
26K
|
2
|
|